Cargando…

Mechanisms of gas transfer impairment utilizing nitric oxide following severe COVID‐19 pneumonitis

Reduced carbon monoxide diffusing capacity (DL(CO)) is common after recovery from severe COVID‐19 pneumonitis. The extent to which this relates to alveolar membrane dysfunction as opposed to vascular injury is uncertain. Simultaneous measurement of nitric oxide diffusing capacity (DL(NO)) and DL(CO)...

Descripción completa

Detalles Bibliográficos
Autores principales: Seccombe, Leigh M., Heath, David, Farah, Claude S., Di Michiel, James R., Veitch, Elizabeth M., Peters, Matthew J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076686/
https://www.ncbi.nlm.nih.gov/pubmed/37020397
http://dx.doi.org/10.14814/phy2.15660
_version_ 1785020186720468992
author Seccombe, Leigh M.
Heath, David
Farah, Claude S.
Di Michiel, James R.
Veitch, Elizabeth M.
Peters, Matthew J.
author_facet Seccombe, Leigh M.
Heath, David
Farah, Claude S.
Di Michiel, James R.
Veitch, Elizabeth M.
Peters, Matthew J.
author_sort Seccombe, Leigh M.
collection PubMed
description Reduced carbon monoxide diffusing capacity (DL(CO)) is common after recovery from severe COVID‐19 pneumonitis. The extent to which this relates to alveolar membrane dysfunction as opposed to vascular injury is uncertain. Simultaneous measurement of nitric oxide diffusing capacity (DL(NO)) and DL(CO) can partition gas diffusion into its two components: alveolar–capillary membrane conductance (D(mCO)) and capillary blood volume (V(C)). We sought to evaluate D(mCO) and V(C) in the early and later recovery periods after severe COVID‐19. Patients attended for post‐COVID‐19 clinical review and lung function testing including DL(NO)/DL(CO). Repeat testing occurred when indicated and comparisons made using t‐tests. Forty‐nine (eight female) subjects (mean ± SD age: 58 ± 13, BMI: 34 ± 8) who had severe COVID‐19 pneumonitis, WHO severity classification of 6 ± 1, and prolonged (21 ± 22 days) hospital stay, were assessed 2 months (61 ± 35 days) post discharge. DL(CO)adj (z‐score −1.70 ± 1.49, 25/49 < lower limit of normal [LLN]) and total lung capacity (z‐score −1.71 ± 1.30) were both reduced. D(mCO) and V(C) and were reduced to a similar extent (z‐score −1.19 ± 1.05 and −1.41 ± 1.20, p = 0.4). Seventeen (one female) patients returned for repeat testing 4 months (122 ± 61 days) post discharge. In this subgroup with more impaired lung function, DL(CO)adj improved but remained below LLN (z‐score −3.15 ± 0.83 vs. −2.39 ± 0.86, p = 0.01), 5/17 improved to >LNN. D(mCO) improved (z‐score −2.05 ± 0.89 vs. −1.41 ± 0.78, p = 0.01) but V(C) was unchanged (z‐score −2.51 ± 0.55 vs. −2.29 ± 0.59, p = 0.16). Alveolar membrane conductance is abnormal in the earlier recovery phase following severe COVID‐19 but significantly improves. In contrast, reduced V(C) persists. These data raise the possibility that persisting effects of acute vascular injury may contribute to gas diffusion impairment long after severe COVID‐19 pneumonitis.
format Online
Article
Text
id pubmed-10076686
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-100766862023-04-07 Mechanisms of gas transfer impairment utilizing nitric oxide following severe COVID‐19 pneumonitis Seccombe, Leigh M. Heath, David Farah, Claude S. Di Michiel, James R. Veitch, Elizabeth M. Peters, Matthew J. Physiol Rep Original Articles Reduced carbon monoxide diffusing capacity (DL(CO)) is common after recovery from severe COVID‐19 pneumonitis. The extent to which this relates to alveolar membrane dysfunction as opposed to vascular injury is uncertain. Simultaneous measurement of nitric oxide diffusing capacity (DL(NO)) and DL(CO) can partition gas diffusion into its two components: alveolar–capillary membrane conductance (D(mCO)) and capillary blood volume (V(C)). We sought to evaluate D(mCO) and V(C) in the early and later recovery periods after severe COVID‐19. Patients attended for post‐COVID‐19 clinical review and lung function testing including DL(NO)/DL(CO). Repeat testing occurred when indicated and comparisons made using t‐tests. Forty‐nine (eight female) subjects (mean ± SD age: 58 ± 13, BMI: 34 ± 8) who had severe COVID‐19 pneumonitis, WHO severity classification of 6 ± 1, and prolonged (21 ± 22 days) hospital stay, were assessed 2 months (61 ± 35 days) post discharge. DL(CO)adj (z‐score −1.70 ± 1.49, 25/49 < lower limit of normal [LLN]) and total lung capacity (z‐score −1.71 ± 1.30) were both reduced. D(mCO) and V(C) and were reduced to a similar extent (z‐score −1.19 ± 1.05 and −1.41 ± 1.20, p = 0.4). Seventeen (one female) patients returned for repeat testing 4 months (122 ± 61 days) post discharge. In this subgroup with more impaired lung function, DL(CO)adj improved but remained below LLN (z‐score −3.15 ± 0.83 vs. −2.39 ± 0.86, p = 0.01), 5/17 improved to >LNN. D(mCO) improved (z‐score −2.05 ± 0.89 vs. −1.41 ± 0.78, p = 0.01) but V(C) was unchanged (z‐score −2.51 ± 0.55 vs. −2.29 ± 0.59, p = 0.16). Alveolar membrane conductance is abnormal in the earlier recovery phase following severe COVID‐19 but significantly improves. In contrast, reduced V(C) persists. These data raise the possibility that persisting effects of acute vascular injury may contribute to gas diffusion impairment long after severe COVID‐19 pneumonitis. John Wiley and Sons Inc. 2023-04-05 /pmc/articles/PMC10076686/ /pubmed/37020397 http://dx.doi.org/10.14814/phy2.15660 Text en © 2023 The Authors. Physiological Reports published by Wiley Periodicals LLC on behalf of The Physiological Society and the American Physiological Society. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Seccombe, Leigh M.
Heath, David
Farah, Claude S.
Di Michiel, James R.
Veitch, Elizabeth M.
Peters, Matthew J.
Mechanisms of gas transfer impairment utilizing nitric oxide following severe COVID‐19 pneumonitis
title Mechanisms of gas transfer impairment utilizing nitric oxide following severe COVID‐19 pneumonitis
title_full Mechanisms of gas transfer impairment utilizing nitric oxide following severe COVID‐19 pneumonitis
title_fullStr Mechanisms of gas transfer impairment utilizing nitric oxide following severe COVID‐19 pneumonitis
title_full_unstemmed Mechanisms of gas transfer impairment utilizing nitric oxide following severe COVID‐19 pneumonitis
title_short Mechanisms of gas transfer impairment utilizing nitric oxide following severe COVID‐19 pneumonitis
title_sort mechanisms of gas transfer impairment utilizing nitric oxide following severe covid‐19 pneumonitis
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076686/
https://www.ncbi.nlm.nih.gov/pubmed/37020397
http://dx.doi.org/10.14814/phy2.15660
work_keys_str_mv AT seccombeleighm mechanismsofgastransferimpairmentutilizingnitricoxidefollowingseverecovid19pneumonitis
AT heathdavid mechanismsofgastransferimpairmentutilizingnitricoxidefollowingseverecovid19pneumonitis
AT farahclaudes mechanismsofgastransferimpairmentutilizingnitricoxidefollowingseverecovid19pneumonitis
AT dimichieljamesr mechanismsofgastransferimpairmentutilizingnitricoxidefollowingseverecovid19pneumonitis
AT veitchelizabethm mechanismsofgastransferimpairmentutilizingnitricoxidefollowingseverecovid19pneumonitis
AT petersmatthewj mechanismsofgastransferimpairmentutilizingnitricoxidefollowingseverecovid19pneumonitis